Notably, although the interaction of MAX and MYC is considered to be activating, mutations in the MAX gene resulting in pheochromocytomas involve loss of function of this protein, whereas the activity of MYC in tumors is elevated [191]. The gene discussed is MYC; the disease is hereditary pheochromocytoma-paraganglioma.